Legible Bio

Shoumik Dabir

Making biotech more legible www.legible.bio

Episodes

  1. Ep 5: Creative Destruction in Biotech with Shelby Newsad

    Jan 30

    Ep 5: Creative Destruction in Biotech with Shelby Newsad

    Shelby Newsad is an early stage venture investor at Compound. I’ve long admired her thesis work in publicly sharing how biotech could unfold over the next decade. In this conversation, we talk about everything from decentralized clinical trials to incumbent vs startup advantages in biotech. Hope you enjoy! Watch on X, YouTube, or Spotify Chapters 07:21 Platform vs Product 14:25 Creative Destruction in Biotech 23:54 Decentralized Science and Crypto 30:35 Careful with Gray Label Peptides 35:34 Accelerating Human Clinical Trials 45:36 The Role of Virtual Cell Models 50:01 The Evolution of Bio-Manufacturing 53:34 Consumer Biotech: The Next Frontier 58:51 Implications of Looksmaxxing Resources mentioned Compound Research Day: Rapid in vivo Iteration Everything Is Tuberculosis: The History and Persistence of Our Deadliest Infection by John Green This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.legible.bio

    1h 4m
  2. Ep 4: Bioelectricity with anabology

    12/10/2025

    Ep 4: Bioelectricity with anabology

    This was an amazing conversation—I learned a lot and hope you do too. Watch on YouTube here. More on RJ/ anabology here. More on Aion Biosciences here. Also check out skin.food (would personally recommend!) Some resources mentioned: literature.bio - RJ’s website where he recommends reading the works of Sidney Fox and Ray Peat Chapters 00:00 - Background and Bioelectricity 10:19 - Gilbert Ling 28:27 - Raymond Damidian 45:23 - What is Structured Water? 49:32 - Are Small Molecule Approaches a Dead End? 59:30 - Building Aion Biosciences in St Louis. MO 01:05:12 - Consciousness and Origin of Life 01:11:46 - Cosmetics Sidequest (skin.food) This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.legible.bio

    1h 16m
  3. Ep 2: Evolution of Biotech with Keith Robison

    11/17/2025

    Ep 2: Evolution of Biotech with Keith Robison

    Watch on YouTube here Chapters00:00 Evolution of Biotech: Past and Present05:29 Understanding Sequencing: Basics and Importance10:07 The Drug Development Process: Then and Now17:18 The Shift from Small Molecules to Biologics22:11 Chance and Unpredictability in Drug Discovery26:35 Sequencing Technologies: DNA, RNA, and Proteins44:12 Exciting Innovations in Sequencing53:53 Synthetic Biology and Ginkgo’s Vision01:01:49 Automation in Biotechnology01:10:33 Recommended Reads for Biotech EnthusiastsResources mentioned * Keith’s blog: * The Billion Dollar Molecule by Barry Werth * For Blood or Money by Nathan Vardi * The Coming Plague by Laurie Garrett * Plenty of Room at the Bottom by Richard Feynman This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.legible.bio

    1h 17m
  4. Ep 1: Democratizing DNA sequencing with Ana Cornell

    11/17/2025

    Ep 1: Democratizing DNA sequencing with Ana Cornell

    Watch on YouTube here Learn more about what Ana’s building here ChaptersChapters00:00 Circus to Genetics05:14 Building a Sequencer13:26 The Future of Sequencing: Decentralization and Accessibility18:31 Challenges in Manufacturing and Scaling21:21 Sequencing in Breweries23:47 Building a Platform Company29:54 Misunderstandings about Sequencing35:09 What Does It Mean Go Fast in Biotech?39:36 The Biotech Race: US vs. China47:22 Family and Startups54:33 The Role of Personality Types in Leadership This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.legible.bio

    1h 10m
  5. Ep 0: Biotech theses with Andrew Hui

    11/17/2025

    Ep 0: Biotech theses with Andrew Hui

    Also watch on YouTube 00:36 Journey into Biotech: From Education to Industry03:23 Investing in Biotech: Early Experiences and Lessons Learned06:11 Starting a Biotech Company: The Initial Steps09:14 Developing Technology in Biomanufacturing11:55 Challenges of Venture Capital in Biotech14:45 Reflections on Business Strategy and Acquisitions17:39 Exploring the Mining Industry: Insights and Parallels20:39 Comparing Mining and Biotech: Investment Strategies23:10 Final Thoughts on Mining and Biotech Investments26:32 Exploring Emerging Markets and Biotech29:29 The Distressed Biotech IP Thesis32:51 Danaher and the Power of Operational Efficiency36:45 The Challenges of Venture Capital in Biotech41:29 The Role of CROs in Biotech45:34 Critique of the Biotech Industry55:21 The Importance of Biosecurity in Biotech01:05:29 Biosecurity and Monitoring Layers01:07:28 Ginkgo Biosecurity: The Bio Radar Concept01:11:50 The Role of Sequencing in Biosecurity01:17:56 China’s National Priority in Sequencing Technology01:23:32 The Future of Drug Development and Sequencing01:32:19 Short Read vs Long Read Sequencing This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.legible.bio

    1h 35m
  • 5 Episodes

About

Making biotech more legible www.legible.bio

Information

  • Creator
    Shoumik Dabir
  • Years Active
    2025 - 2026
  • Episodes
    5
  • Rating
    Explicit
  • Copyright
    © Shoumik Dabir
  • Show Website
    Legible Bio